Ye Han
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- PARP inhibition in cancer therapy
- Cancer Cells and Metastasis
Papers in
-
- Circular RNAs in diseases 5
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 4
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 6
- Co-authors
- Qiaoming Zhi (20 shared papers)Xiaofeng Xue (11 shared papers)Daiwei Wan (9 shared papers)Xiaobo Guo (8 shared papers)Yuting Kuang (7 shared papers)Zhihua Xu (8 shared papers)Xiaopeng Yu (2 shared papers)Pu Li (4 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (5 papers)Tumor Biology (3 papers)Clinical and Translational Medicine (2 papers)International Journal of Thermal Sciences (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Ye Han
41 papers receiving 783 citations
Peers
Comparison fields: 5 of 84
- Cancer Research 250
- Oncology 192
- Molecular Biology 466
- Endocrine and Autonomic Systems 25
- Aging 7
Countries citing papers authored by Ye Han
This map shows the geographic impact of Ye Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Han more than expected).
Fields of papers citing papers by Ye Han
This network shows the impact of papers produced by Ye Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Han. The network helps show where Ye Han may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 74 | |
| 2 | 2020 | 50 | |
| 3 | Metformin reverses PARP inhibitors-induced epithelial-mesenchymal transition and PD-L1 upregulation in triple-negative breast cancer. | 2019 | 38 |
| 4 | Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer. | 2020 | 36 |
| 5 | 2014 | 35 | |
| 6 | 2014 | 34 | |
| 7 | 2014 | 34 | |
| 8 | 2015 | 34 | |
| 9 | 2020 | 33 | |
| 10 | 2014 | 31 | |
| 11 | 2014 | 30 | |
| 12 | 2024 | 29 | |
| 13 | Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cells. | 2019 | 29 |
| 14 | 2018 | 28 | |
| 15 | 2014 | 28 | |
| 16 | 2014 | 25 | |
| 17 | 2015 | 24 | |
| 18 | 2019 | 23 | |
| 19 | 2021 | 19 | |
| 20 | 2018 | 17 |
About Ye Han
Ye Han is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Physiology, having authored 45 papers that have together received 788 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (5 papers), PARP inhibition in cancer therapy (5 papers), Epigenetics and DNA Methylation (4 papers), RNA modifications and cancer (4 papers), Textile materials and evaluations (3 papers) and Thermoregulation and physiological responses (3 papers). The work is most often cited by research in Cancer Research (250 citations), Oncology (192 citations), Molecular Biology (466 citations), Endocrine and Autonomic Systems (25 citations) and Aging (7 citations). Ye Han has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Qiaoming Zhi, Xiaofeng Xue, Daiwei Wan, Xiaobo Guo, Yuting Kuang, Zhihua Xu, Xiaopeng Yu, Pu Li, Min Jiang and Jennifer L. Hsu. Their work appears in journals such as Biomedicine & Pharmacotherapy, Tumor Biology, Clinical and Translational Medicine, International Journal of Thermal Sciences and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.